The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after ...

Shares of Pfizer Inc. gave up ground in early Tuesday trading, after the drug giant reported a decline in revenue, as ...

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after ...

Taking a closer look at the numbers, Comirnaty sales slipped 19% globally to $1.15 billion, the Prevnar franchise experienced a 3% global sales decline to $1.7 billion, and Abrysvo’s performance ...

Pfizer COVID-19 vaccine sales drop 25% after confusing government guidance on the shot - Previously, fall is when Americans ...

Pfizer’s sales of its COVID-19 vaccine, Comirnaty, fell sharply by 25% in the U.S. during the third quarter of 2025, dropping ...